Table 1.
Patient characteristics on admission
| Insulin analogs (glulisine/glargine) | Human insulin (NPH/regular) | |
|---|---|---|
| n | 34 | 34 |
| Age (years) | 39 ± 12 | 38 ± 12 |
| Sex (male/female) | 22/12 | 23/11 |
| Race | ||
| African American | 29 | 27 |
| Caucasian | 4 | 6 |
| Other | 1 | |
| BMI (kg/m2) | 29 ± 9 | 27 ± 7 |
| Precipitating cause of DKA | ||
| Poor compliance | 20 (59) | 27 (79) |
| New-onset diabetes | 6 (18) | |
| Other medical illness | 8 (23) | 7 (21) |
| Glucose (mg/dl) | 529 ± 173 | 564 ± 164 |
| Bicarbonate (mEq/l) | 12.8 ± 4.5 | 12.5 ± 5.0 |
| Venous pH | 7.2 ± 0.1 | 7.1 ± 0.2 |
| Anion gap (mEq/l) | 22 ± 6 | 22 ± 6 |
| β-Hydroxybutyrate (mmol/l) | 8.0 ± 3.4 | 7.4 ± 3.3 |
| A1C (%) | 11.7 ± 2.2 | 11.7 ± 2.9 |
Data are means ± SD or n (%).